Vidya G Doddawad, BDS, MDS

Articles by Vidya G Doddawad, BDS, MDS

Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer

ByVidya G Doddawad, BDS, MDS,B.M. Gurupadayya,Vidya CS,Shivananda S, BDS, MDS,Karthikeya Patil,R. Sumukh Bharadwaj

April 16th 2025

Human saliva may hold antioxidants that are able to monitor the oral cavity's oxidative processes and offer guidance for the development of new drugs.

Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report

BySahith Kumar Shetty, BDS, MDS,Vidya G Doddawad, BDS, MDS,Shyam Sundar S, BDS, MDS,Shivananda S, BDS, MDS

November 14th 2023

A case study by Sahith Kumar Shetty, BDS, MDS, et al reviews the need for a multidisciplinary approach to the treatment of patients with Gorlin-Goltz syndrome.

Latest Updated Articles

Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer
April 16th 2025
Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report
November 14th 2023

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)